Feature Channels: Diabetes

Filters close
Released: 11-Aug-2021 4:10 PM EDT
Do Some Diabetes Drugs Reduce the Risk of Alzheimer’s?
American Academy of Neurology (AAN)

MINNEAPOLIS – People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer’s disease, when compared to both people with type 2 diabetes not taking the drugs and people without diabetes. The new study, published in the August 11, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology, also found people taking these drugs, called dipeptidyl peptidase-4 inhibitors, showed slower cognitive decline than people in the other two groups.

Released: 10-Aug-2021 9:00 AM EDT
Research Gaps on ‘Rare’ Sugars that Show Promise as Alternative Sweeteners
Institute for the Advancement of Food and Nutrition Sciences

Uniquely metabolized sugars naturally present in small amounts in foods such as honey, maple syrup, and certain fruits are alternative sweeteners with potential health benefits. However, controlled trials are needed before their full benefits may be realized.

Released: 10-Aug-2021 7:00 AM EDT
Frequent Breaks from Sitting May Improve Daily Blood Sugar Fluctuations
American Physiological Society (APS)

Frequent activity breaks from sitting may improve fasting blood sugar (glucose) levels and stabilize daily fluctuations, according to new research. The study, the first of its length to explore the effects of activity breaks in “free-living” conditions, is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism. It was chosen as an APSselect article for August.

Released: 9-Aug-2021 11:05 AM EDT
New Diabetes Management Fellowship Recipient to Address Barriers to Continuous Glucose Monitoring Use in Adolescents and Families
Association of Diabetes Care & Education Specialists (ADCES)

The Association of Diabetes Care & Education Specialists Foundation and the Certification Board for Diabetes Care and Education are proud to award Kelsey Howard, Ph.D., a one-year fellowship in integrated diabetes management.

Released: 9-Aug-2021 8:30 AM EDT
Do Vitamin D Supplements Offer Kidney-Related Benefits for Individuals With High Diabetes Risk?
American Society of Nephrology (ASN)

• In a clinical trial of individuals at high risk for developing type 2 diabetes, which is the leading cause of kidney disease, vitamin D supplementation did not have significant effects on kidney health. • As participants were not selected according to baseline vitamin D levels, investigators cannot exclude a kidney benefit for individuals with vitamin D deficiency.

Released: 6-Aug-2021 8:05 AM EDT
An Overactive Sweet Tooth May Spell Trouble for Our Cellular Powerplants
Van Andel Institute

GRAND RAPIDS, Mich. (August 3, 2021) — The average American eats roughly 22 teaspoons of added sugar a day — more than three times the recommended amount for women and more than double the recommended amount for men.

Released: 4-Aug-2021 12:55 PM EDT
Most Comprehensive Review Yet of Keto Diets Finds Heart Risks, Cancer Risk, Dangers to Pregnant Women and Kidney Patients
Physicians Committee for Responsible Medicine

In the most comprehensive analysis yet of ketogenic (keto) diets, a review in Frontiers in Nutrition finds keto diets place pregnant women and kidney disease patients at risk of adverse health effects.

Released: 4-Aug-2021 11:30 AM EDT
Artificial Pancreas Trialled for Outpatients with Type 2 Diabetes for First Time
University of Cambridge

An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis.

Released: 4-Aug-2021 11:25 AM EDT
Common Weight-Loss Drug Successfully Targets Fat That Can Endanger Heart Health
UT Southwestern Medical Center

DALLAS – August 4, 2021 – Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular risk, once-daily liraglutide combined with lifestyle interventions significantly lowered two types of fat that have been associated with risk to heart health: visceral fat and ectopic fat.

Released: 4-Aug-2021 11:05 AM EDT
Clinical Trial Shows Injectable Weight Loss Drug Directly Reduces Abdominal Fat
University Hospitals Cleveland Medical Center

A clinical trial found liraglutide, an injectable weight loss medication, reduced intra-abdominal and liver fat in participants more than placebo in addition to a low-calorie diet and increased physical activity.

Released: 3-Aug-2021 7:00 AM EDT
Low-fiber Diet May Lead to Gut Infection Even if You’re Not Overweight
American Physiological Society (APS)

Diet, more than body mass, may play a role in the risk for gut infection, and eating more fiber could be the key to prevention. The study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.

Released: 30-Jul-2021 4:45 PM EDT
Medication Approved for Diabetes Being Tested for Treatment of Cocaine Use Disorder
University of Texas Health Science Center at Houston

With overdose rates involving cocaine soaring nearly 27% in 2020, researchers at The University of Texas Health Science Center at Houston (UTHealth) hope that a clinical trial combining a medication approved for the treatment of Type 2 diabetes with cognitive behavioral therapy (CBT) can help prevent relapse in cocaine use disorder patients.

Released: 29-Jul-2021 3:50 PM EDT
Wayne State Researcher Secures $2.3 Million in NIH Funding for Metabolic Research
Wayne State University Division of Research

A Wayne State University School of Medicine researcher has been awarded a $2.3 million grant by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, to support research in circadian RNA modification in metabolic disease.

Released: 27-Jul-2021 2:25 PM EDT
Structural Racism and Inequitable Pediatric Diabetes Care
University of Pennsylvania School of Nursing

Data show racial disparities in type 1 diabetes treatment and outcomes in non-Hispanic Black (NHB) children in the US. NHB children are less likely to be treated with diabetes technology, have poorer glycemic control and higher rates of diabetes complications and diabetes-related mortality than non-Hispanic white children. There is much to be done to ensure equitable care, but as yet, structural racism has not been a focus.

Released: 26-Jul-2021 6:05 PM EDT
Patients Report Long-Term Favorable Effects of Weight Loss Surgery in Their Daily Lives
Cleveland Clinic

A new analysis from the STAMPEDE trial shows that over the course of five years, patients who had bariatric and metabolic surgery to treat uncontrolled type 2 diabetes reported greater physical health, more energy, less body pain, and less negative effects of diabetes in their daily lives, compared with patients who had medical therapy alone for their diabetes. Long-term changes in psychosocial and emotional quality of life measures were not significantly different between the surgical and medical groups. The research was published in the Annals of Surgery.

Released: 26-Jul-2021 5:55 PM EDT
Hackensack Meridian Hackensack University Medical Center Earns Joint Commission Recertification for Advanced Diabetes Management
Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center has been recertified by the Joint Commission, a national accreditation organization, in Advanced Diabetes Management. This Disease Specific Certification demonstrates that Hackensack University Medical Center meets or exceeds national standards for diabetes care.

Released: 26-Jul-2021 11:10 AM EDT
No More Finger Pricks: A Continuous Glucose Monitor Benefits Patients with Diabetes in More Ways Than One
Michigan Medicine - University of Michigan

For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.

Released: 23-Jul-2021 5:15 PM EDT
New Biomarkers May Detect Early Eye Changes That Can Lead to Diabetes-Related Blindness
Indiana University

Optometry researchers have identified new biomarkers that may advance the early detection of diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in U.S. adults.

Released: 20-Jul-2021 3:10 PM EDT
Researchers Develop Novel Method for Glucagon Delivery
University of Notre Dame

In a new study, published in the Journal of the American Chemical Society, Matthew Webber, associate professor of chemical and biomolecular engineering, is rethinking the traditional use of glucagon as an emergency response by administering it as a preventive measure.

14-Jul-2021 6:05 AM EDT
Babies at Risk for Diabetes May Have Microbiota Restored
Rutgers University-New Brunswick

Newborns at risk for Type 1 diabetes because they were given antibiotics may have their gut microorganisms restored with a maternal fecal transplant, according to a Rutgers study.

Released: 20-Jul-2021 10:45 AM EDT
JDRF and the Association of Diabetes Care & Education Specialists Announce New Partnership
Association of Diabetes Care & Education Specialists (ADCES)

JDRF, the leading global funder of Type 1 diabetes research, and the Association of Diabetes Care & Education Specialists, the largest organization dedicated to diabetes care and education specialists, proudly announce a new partnership.

Released: 14-Jul-2021 9:30 AM EDT
Antidepressants May Improve Outcomes in People with Diabetes and Depression
Endocrine Society

People with diabetes and depression who take antidepressants may have a lower risk of death and of serious diabetes complications, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Released: 12-Jul-2021 1:05 PM EDT
American Thyroid Association Announces Award Recipients
American Thyroid Association

Esteemed clinicians and researchers recognized for their contributions to American Thyroid Association, thyroid cancer and thyroid disease research.

Released: 8-Jul-2021 10:15 AM EDT
Precision medicine helps identify “at-risk rapid decliners” in early-stage kidney disease
Michigan Medicine - University of Michigan

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.

Released: 2-Jul-2021 8:05 AM EDT
University of Kentucky Study Finds Time-Restricted Eating May Reduce Diabetes-Related Hypertension
University of Kentucky

A new University of Kentucky College of Medicine study suggests that time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by elevated blood pressure at night.

Released: 1-Jul-2021 5:20 PM EDT
Pesquisadores da Mayo Clinic exploram abordagem personalizada para medicamentos antiobesidade
Mayo Clinic

As iniciativas de medicina individualizada se concentram principalmente nas doenças raras ou no câncer. Pouco foi tentado para individualizar o tratamento de doenças crônicas não transmissíveis, como a obesidade, uma doença crônica recorrente e uma causa primária de diabetes tipo 2, gordura hepática, doenças cardiovasculares e câncer.

Released: 1-Jul-2021 5:05 PM EDT
Investigadores de Mayo Clinic exploran método personalizado para medicamentos contra la obesidad
Mayo Clinic

Las iniciativas de la medicina personalizada se concentran, principalmente, en las enfermedades raras o en el cáncer. Han sido escasos los intentos por personalizar el tratamiento de enfermedades crónicas no contagiosas, como la obesidad, que es una afección crónica y recurrente, además de causa principal para diabetes tipo 2, hepatopatía grasa, enfermedad cardiovascular y cáncer.

Released: 1-Jul-2021 11:15 AM EDT
Study: Antidiabetic Drug Causes Double the Weight Loss of Competitor in Type 2 Diabetes Patients
University at Buffalo

Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.

Released: 30-Jun-2021 5:55 PM EDT
A promising new pathway to treating type 2 diabetes
University of Arizona

This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal disease into a manageable condition.

Released: 30-Jun-2021 2:55 PM EDT
Newly Discovered Proteins Provide Protection Against Progression of Kidney Disease in Diabetes
Joslin Diabetes Center

Elevated levels of three specific circulating proteins are associated with protection against kidney failure in diabetes, according to research from the Joslin Diabetes Center in Boston.

Released: 30-Jun-2021 2:25 PM EDT
Wayne State University and Henry Ford Health System Announce New Initiative in Cardiometabolic Health and Disease
Wayne State University Division of Research

Wayne State University and Henry Ford Health System announced today the launch of a basic and translational research initiative in Cardiometabolic Health and Disease as a thematic focus for program growth.

Released: 30-Jun-2021 11:20 AM EDT
Endocrine Society Journals earn higher Impact Factors for 2020
Endocrine Society

Endocrine Society Journals experienced large Impact Factor increases, led by Endocrine Reviews, according to Clarivate’s recently released annual Journal Citation Report (JCR) for 2020.

23-Jun-2021 10:10 AM EDT
Antacids May Improve Blood Sugar Control in People with Diabetes
Endocrine Society

Antacids improved blood sugar control in people with diabetes but had no effect on reducing the risk of diabetes in the general population, according to a new meta-analysis published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Released: 21-Jun-2021 9:55 AM EDT
Endocrine Society Mourns the Passing of Dr. Jean D. Wilson
Endocrine Society

The Endocrine Society leadership is saddened to announce the passing of renowned member and Past President Jean D. Wilson, M.D. Wilson was President of the Endocrine Society from 1989 to 1990 and a member for almost fifty years.

Released: 18-Jun-2021 3:10 PM EDT
Undiagnosed and Untreated Disease Identified in Rural South Africa
University of Alabama at Birmingham

A comprehensive health-screening program in rural northern KwaZulu-Natal, South Africa, has found a high burden of undiagnosed or poorly controlled non-communicable diseases, according to a study published in The Lancet Global Health.

Released: 17-Jun-2021 4:15 PM EDT
UNC Researchers Lead Study of Diabetes Treatment of COVID-19 Patients
University of North Carolina School of Medicine

Diabetes is one of the comorbidities most strongly associated with severe COVID-19 in the US, and data from early in the pandemic suggested individuals with type 2 diabetes faced twice the risk of death from COVID-19 and a greater risk of requiring hospitalization and intensive care. A new study shows best treatment options.

Released: 15-Jun-2021 12:45 PM EDT
Beth Israel Lahey Health and Joslin Diabetes Center Sign Definitive Agreement
Beth Israel Lahey Health

Beth Israel Lahey Health (BILH) and Joslin Diabetes Center (Joslin) have signed a definitive agreement under which Joslin will join BILH and bring to the system its expertise as a world-renowned center of excellence in diabetes research, education and clinical care.

   
Released: 15-Jun-2021 9:00 AM EDT
Media Advisory: June 23rd Today’s Dietitian Webinar
Monday Campaigns

Sharon Palmer, MSFS, RDN, will moderate an expert panel of speakers as they share ways of integrating a plant-forward diet and other healthy behaviors into daily routines so people at-risk or with prediabetes can dramatically reduce their likelihood of developing type 2 diabetes or other major health complications.

   
Released: 15-Jun-2021 8:05 AM EDT
Why Telehealth is Not Meeting the Needs of African Americans with Diabetes
Thomas Jefferson University

Mistrust in physicians kept some Black patients with diabetes from using these services during the pandemic

9-Jun-2021 12:40 PM EDT
New Study Finds Weight-Loss Surgery Less Commonly Used in States with Highest Rates of Obesity
American Society for Metabolic and Bariatric Surgery (ASMBS)

A new study released today finds residents in several states with the highest obesity rates in the country are among the least likely to undergo weight-loss surgery, long considered the standard of care for severe obesity and related diseases including type 2 diabetes and heart disease.

9-Jun-2021 12:30 PM EDT
ASMBS 2021 Annual Meeting Select Study Highlights
American Society for Metabolic and Bariatric Surgery (ASMBS)

The risk of stroke is cut by more than half in what researchers believe is the largest patient sample size ever for a study on bariatric surgery and its effect on ischemic cerebrovascular disease (96,094 bariatric surgery patients and 1,533,725 matched nonsurgical patients with obesity).

9-Jun-2021 12:40 PM EDT
ASMBS 2021 Annual Meeting Invited Papers
American Society for Metabolic and Bariatric Surgery (ASMBS)

Long-Term Outcomes of Duodenal Switch (DS) Versus Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy (SADI-S): A Matched Cohort Study

7-Jun-2021 9:45 AM EDT
Major Study of Diabetes Trends Shows Americans’ Blood Sugar Control is Getting Worse
Johns Hopkins Bloomberg School of Public Health

Blood sugar control among adults with diabetes in the United States declined significantly in the past decade, according to a nationwide study from researchers at the Johns Hopkins Bloomberg School of Public Health.

Released: 8-Jun-2021 12:55 PM EDT
Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation
UC San Diego Health

Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.

1-Jun-2021 9:00 AM EDT
New Research Examines the Science Behind Superfoods
American Society for Nutrition (ASN)

Superfoods like turmeric and honey have long been recognized for their ability to promote health and wellness. New studies being presented at NUTRITION 2021 LIVE ONLINE take a closer look at the science behind the health benefits of superfoods.

Released: 7-Jun-2021 10:45 AM EDT
Restoring gut microbes missing in early life dysbiosis can reduce the risk of colitis in genetically prone mice
University of Chicago Medical Center

A new study at the University of Chicago has determined that restoring a single microbial species — Bacteroides sp. CL1-UC (Bc) — to the gut microbiome at a key developmental timepoint can prevent antibiotic-induced colitis in a mouse model of the condition.

Released: 4-Jun-2021 10:00 AM EDT
Giving Brown Fat A Boost to Fight Type 2 Diabetes
UT Southwestern Medical Center

DALLAS – June 4, 2021 – Increasing a protein concentrated in brown fat appears to lower blood sugar, promote insulin sensitivity, and protect against fatty liver disease by remodeling white fat to a healthier state, a new study led by UT Southwestern scientists suggests. The finding, published online in Nature Communications, could eventually lead to new solutions for patients with diabetes and related conditions.

Released: 3-Jun-2021 12:00 PM EDT
UCI-led team develops transplant biomaterial that doesn’t trigger immune response
University of California, Irvine

Irvine, Calif., June 3, 2021 — A multidisciplinary research team led by Jonathan Lakey, Ph.D., professor of surgery and biomedical engineering at the University of California, Irvine, has developed a biomaterial for pancreatic islet transplants that doesn’t trigger the body’s immune response. Based on stem cell technology, hybrid alginate offers a possible long-term treatment for Type 1 diabetes, an autoimmune reaction that destroys pancreatic islets’ beta cells, which regulate blood glucose levels.



close
3.02284